Further indications for Eliquis
November 22, 2012Sales and Marketing BMS, Eliquis, NVAF, Pfizer, Pradaxa, Xarelto
Bristol-Myers Squibb and Pfizer’s oral blood-thinner Eliquis has been approved in Europe to prevent stroke in patients with nonvalvular atrial …
Jim Easton steps down from NHS Commissioning Board role
November 22, 2012Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Easton, NHS, NHS Commissioning Board
Jim Easton has stepped down from his role as national director: Transformation at the NHS Commissioning Board (CB) and his …
New NHS, new customers – tips from the frontline
November 21, 2012Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CCGs, Commissioning Board, Dixon, NHS, Sobanja, pharmafile
In the noisy and continuing debate over health reform, it is worth remembering the aim of the coalition government’s health …
Xarelto gets new EU approval
November 21, 2012Sales and Marketing AF, Bayer, DVT, Xarelto
Bayer’s oral anticoagulant Xarelto has extended its licence in Europe to treat pulmonary embolism (PE) and prevent recurrent deep vein …
Almirall appoints first woman to its Board
November 21, 2012Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Almirall
Karin Louise Dorrepaal is the first woman to join Almirall’s ten-member Board of directors. Dorrepaal, who is Dutch, has extensive …
Pfizer in cystic fibrosis alliance
November 21, 2012Research and Development, Sales and Marketing CFFT, CFTR, FDA, Pfizer
Pfizer and Cystic Fibrosis Foundation Therapeutics (CFFT) have signed a six-year pre-clinical deal to find new drugs to treat the …
Avastin shows brain cancer benefit
November 20, 2012Research and Development, Sales and Marketing Cancer, FDA, Merck, Roche, avastin, brain
In a Phase III trial, Roche’s Avastin has helped people with newly-diagnosed glioblastoma (GBM) live longer without their disease worsening. …
Catalent wields axe at UK plant
November 20, 2012Manufacturing and Production CTS, Catalent, Swindon
Around 45 staff at Catalent’s pharmaceutical facility in Swindon, UK, are to lose their jobs because of fluctuating demand for …
Pharma manufacturing news in brief
November 20, 2012Manufacturing and Production Alfa Laval, Boehringer, Fujifilm, Health Canada, Novartis
Our latest round-up of manufacturing news includes a facility contract for Alfa Laval, plus updates from Fujifilm, Novartis, Boehringer Ingelheim …
Senior appointments at NHS Commissioning Board
November 20, 2012Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CB, CCGs, NHS
The NHS Commissioning Board (NHS CB) has made several national appointments to the Medical Directorate. Barry Cockcroft (currently chief dental …
Roquette fined $4.1m for water pollution
November 20, 2012Manufacturing and Production DoJ, EPA, Roquette
The US unit of French ingredients producer Roquette Freres has been fined $4.1m for failing to control the discharge of …
Boehringer licenses high-pressure production technology
November 20, 2012Manufacturing and Production BaroFold, Boehringer Ingelheim
Boehringer Ingelheim has licensed a new technology from BaroFold which could improve the efficiency of biopharmaceutical production processes. Colorado, US-based …
SMC put under review
November 20, 2012Sales and Marketing Alex Neil, NICE, SMC, Scotland
The Scottish Medicines Consortium (SMC) has been put under the spotlight in two reviews ordered by Scotland’s health secretary Alex …
What can pharma can learn from Steve Jobs?
November 19, 2012Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Apple, Steve Jobs, pharma
“Creativity is just connecting things. When you ask creative people how they did something, they feel a little guilty because …
Novartis treatments set for approval
November 19, 2012Sales and Marketing Bexsaro, CHMP, Novartis, exjade
Two Novartis drugs, meningococcal vaccine Bexsero and iron chelation therapy Exjade, have been given positive opinions by the CHMP, with …
European nod for Sanofi drugs
November 19, 2012Research and Development, Sales and Marketing CHMP, Sanofi
Two of Sanofi’s key drugs have cleared the penultimate hurdle to approval in Europe with a recommendation from the CHMP. …
Daiichi Sankyo chief executive elected NPC chairman of the Board
November 19, 2012Manufacturing and Production, Research and Development, Sales and Marketing Daiichi Sankyo
The National Pharmaceutical Council (NPC) has announced that Daiichi Sankyo president and chief executive John Gargiulo has been elected chairman …
Implementation of IHW ‘patchy’
November 16, 2012Sales and Marketing CCGs, IHW, NHS
An NHS initative which is supposed to drive public health forward is in danger of having only a limited impact, …
The future is bright – but don’t rely on emerging markets
November 16, 2012Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing China, emerging markets, industry, pwC
The pharma industry could be “on the cusp of a golden era” of renewed productivity and earnings – but only …
Sanofi appoints Gary Nabel as chief scientific officer
November 16, 2012Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Nabel, Sanofi
Sanofi has announced the appointment of Dr Gary Nabel, senior VP, chief scientific officer and deputy to the president for …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
